Hartmann A - Search Results

1

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.

Lindskrog SV, Prip F, Lamy P, Taber A, Groeneveld CS, Birkenkamp-Demtröder K, Jensen JB, Strandgaard T, Nordentoft I, Christensen E, Sokac M, Birkbak NJ, Maretty L, Hermann GG, Petersen AC, Weyerer V, Grimm MO, Horstmann M, Sjödahl G, Höglund M, Steiniche T, Mogensen K, de Reyniès A, Nawroth R, Jordan B, Lin X, Dragicevic D, Ward DG, Goel A, Hurst CD, Raman JD, Warrick JI, Segersten U, Sikic D, van Kessel KEM, Maurer T, Meeks JJ, DeGraff DJ, Bryan RT, Knowles MA, Simic T, Hartmann A, Zwarthoff EC, Malmström PU, Malats N, Real FX, Dyrskjøt L. Lindskrog SV, et al. Among authors: hartmann a. Nat Commun. 2021 Apr 16;12(1):2301. doi: 10.1038/s41467-021-22465-w. Nat Commun. 2021. PMID: 33863885 Free PMC article.

2

High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancer.

Wild PJ, Kunz-Schughart LA, Stoehr R, Burger M, Blaszyk H, Simon R, Gasser T, Mihatsch M, Sauter G, Hartmann A. Wild PJ, et al. Among authors: hartmann a. Int J Oncol. 2005 Aug;27(2):385-91. Int J Oncol. 2005. PMID: 16010419

3

Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder.

van Oers JM, Adam C, Denzinger S, Stoehr R, Bertz S, Zaak D, Stief C, Hofstaedter F, Zwarthoff EC, van der Kwast TH, Knuechel R, Hartmann A. van Oers JM, et al. Among authors: hartmann a. Int J Cancer. 2006 Sep 1;119(5):1212-5. doi: 10.1002/ijc.21958. Int J Cancer. 2006. PMID: 16570285 Free article.

4

Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger.

Wild PJ, Giedl J, Stoehr R, Junker K, Boehm S, van Oers JM, Zwarthoff EC, Blaszyk H, Fine SW, Humphrey PA, Dehner LP, Amin MB, Epstein JI, Hartmann A. Wild PJ, et al. Among authors: hartmann a. J Pathol. 2007 Jan;211(1):18-25. doi: 10.1002/path.2075. J Pathol. 2007. PMID: 17072825

5

FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.

van Oers JM, Wild PJ, Burger M, Denzinger S, Stoehr R, Rosskopf E, Hofstaedter F, Steyerberg EW, Klinkhammer-Schalke M, Zwarthoff EC, van der Kwast TH, Hartmann A. van Oers JM, et al. Among authors: hartmann a. Eur Urol. 2007 Sep;52(3):760-8. doi: 10.1016/j.eururo.2007.01.009. Epub 2007 Jan 12. Eur Urol. 2007. PMID: 17240035

6

Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tract.

Eiber M, van Oers JM, Zwarthoff EC, van der Kwast TH, Ulrich O, Helpap B, Stoerkel S, Blaszyk H, Cheville J, Sauter G, Wild PJ, Stoehr R, Hofstaedter F, Hartmann A. Eiber M, et al. Among authors: hartmann a. Am J Surg Pathol. 2007 Jun;31(6):938-46. doi: 10.1097/01.pas.0000249448.13466.75. Am J Surg Pathol. 2007. PMID: 17527084

7

[Correlation of FGFR3 mutations and chromosomal alterations in bladder cancer].

Junker K, van Oers JM, Zwarthoff EC, Kania I, Schubert J, Hartmann A. Junker K, et al. Among authors: hartmann a. Verh Dtsch Ges Pathol. 2006;90:151-8. Verh Dtsch Ges Pathol. 2006. PMID: 17867592 German.

8

[Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome].

Giedl J, Wild PJ, Stoehr R, Junker K, Boehm S, van Oers JM, Zwarthoff EC, Blaszyk H, Fine SW, Humphrey PA, Dehner LP, Amin MB, Epstein JI, Hartmann A. Giedl J, et al. Among authors: hartmann a. Verh Dtsch Ges Pathol. 2006;90:253-63. Verh Dtsch Ges Pathol. 2006. PMID: 17867604 German.

9

Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study.

Burger M, van der Aa MN, van Oers JM, Brinkmann A, van der Kwast TH, Steyerberg EC, Stoehr R, Kirkels WJ, Denzinger S, Wild PJ, Wieland WF, Hofstaedter F, Hartmann A, Zwarthoff EC. Burger M, et al. Among authors: hartmann a. Eur Urol. 2008 Oct;54(4):835-43. doi: 10.1016/j.eururo.2007.12.026. Epub 2007 Dec 26. Eur Urol. 2008. PMID: 18166262

10

Fibroblast growth factor receptor 3 mutations in bladder tumors correlate with low frequency of chromosome alterations.

Junker K, van Oers JM, Zwarthoff EC, Kania I, Schubert J, Hartmann A. Junker K, et al. Among authors: hartmann a. Neoplasia. 2008 Jan;10(1):1-7. doi: 10.1593/neo.07178. Neoplasia. 2008. PMID: 18231634 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,397 results

Search Page